A Critical Step Forward in Our Mission to Curate the Genome

At Genomenon, our mission to curate the entire human genome is the driving force behind everything we do. Today, we’re proud to announce a significant milestone in our journey: the acquisition of the Clinical Knowledgebase (CKB) from The Jackson Laboratory. 

Read more

Blazing Trails with Actionable Genomics

Genomenon CEO Mike Klein elaborates on why it’s such an honor to receive the 2023 Frost & Sullivan Technology Innovation Best Practices Award.

Read more

Accelerating Rare Disease Diagnosis with Genomic Data

Genomenon CEO, Mike Klein, shares how Mastermind’s new Disease-Specific Curated Content is helping clinicians discover new treatment options for rare diseases.

Read more

Using Technology to Power Pharma and Clinical Genomics with Mike Klein

Genomenon CEO, Mike Klein met with Mike Maddox, host of ASK, to talk about Genomenon’s use of innovative technology to connect medical professionals with the scientific evidence they need to treat rare diseases and cancers.

Read more

Genomenon is 2020 Company of the Year in Global Clinical Genomics Interpretation

Genomenon was named the 2020 Global Company of the Year in Clinical Genomics Interpretation by Frost & Sullivan today. The distinguished award highlights the superiority of Mastermind as a pioneering and first-in-class genomic database and leading research tool accelerating precision medicine. Below is the report in its entirety.

Read more